Reply to Alffenaar et al

doi:10.1093/cid/ciw679

Comment

. 2017 Jan 1;64(1):105-106.

doi: 10.1093/cid/ciw679. Epub 2016 Oct 26.

Reply to Alffenaar et al

Charles A Peloquin¹, Susan E Dorman², Andrew Vernon³, Giovanni Battista Migliori⁴, Payam Nahid⁵

Affiliations

¹ University of Florida, Gainesville.
² Johns Hopkins University, Baltimore, Maryland.
³ Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ World Health Organization Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri Care and Research Institute, Tradate, Italy.
⁵ University of California, San Francisco.

PMID: 27789610
DOI: 10.1093/cid/ciw679

Comment

Reply to Alffenaar et al

Charles A Peloquin et al. Clin Infect Dis. 2017.

. 2017 Jan 1;64(1):105-106.

doi: 10.1093/cid/ciw679. Epub 2016 Oct 26.

Authors

Charles A Peloquin¹, Susan E Dorman², Andrew Vernon³, Giovanni Battista Migliori⁴, Payam Nahid⁵

Affiliations

¹ University of Florida, Gainesville.
² Johns Hopkins University, Baltimore, Maryland.
³ Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ World Health Organization Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri Care and Research Institute, Tradate, Italy.
⁵ University of California, San Francisco.

PMID: 27789610
DOI: 10.1093/cid/ciw679

No abstract available

PubMed Disclaimer

Comment on

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Nahid P, et al. Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10. Clin Infect Dis. 2016. PMID: 27516382 Free PMC article.
Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians.
Alffenaar JC, Tiberi S, Verbeeck RK, Heysell SK, Grobusch MP. Alffenaar JC, et al. Clin Infect Dis. 2017 Jan 1;64(1):104-105. doi: 10.1093/cid/ciw677. Epub 2016 Oct 6. Clin Infect Dis. 2017. PMID: 27789609 Free PMC article. No abstract available.

Cited by

The Role of Therapeutic Drug Monitoring in Mycobacterial Infections.
Peloquin C. Peloquin C. Microbiol Spectr. 2017 Jan;5(1):10.1128/microbiolspec.tnmi7-0029-2016. doi: 10.1128/microbiolspec.TNMI7-0029-2016. Microbiol Spectr. 2017. PMID: 28084209 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to Alffenaar et al

Affiliations

Reply to Alffenaar et al

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical